Sughanda Khanna, MD in Georgetown, DE - Medicare

Sughanda Khanna, MD is a medicare enrolled "Preventive Medicine - Addiction Medicine" physician in Georgetown, Delaware. Her current practice location is 501 West Market St, Ste 105, Georgetown, Delaware. You can reach out to her office (for appointments etc.) via phone at (302) 303-5491.

Sughanda Khanna is licensed to practice in Maryland (license number D0061099) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1326018060.

Contact Information

	Sughanda Khanna, MD
	501 West Market St, Ste 105, Georgetown, DE 19947
	(302) 303-5491
	Not Available

Physician's Profile

Full Name	Sughanda Khanna
Gender	Female
Speciality
Experience	Years
Location	501 West Market St, Georgetown, Delaware
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Sughanda Khanna attended and graduated from in

NPI Data:

NPI Number: 1326018060
Provider Enumeration Date: 01/25/2006
Last Update Date: 12/27/2022

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Sughanda Khanna such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1326018060	NPI	-	NPPES
405027400	Medicaid	MD

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	C1-0012031 (Delaware)	Secondary
207P00000X	Emergency Medicine	D0061099 (Maryland)	Secondary
207QA0401X	Family Medicine - Addiction Medicine	C1-0012031 (Delaware)	Secondary
2083A0300X	Preventive Medicine - Addiction Medicine	C10012031 (Delaware)	Secondary
2083A0300X	Preventive Medicine - Addiction Medicine	D0061099 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sughanda Khanna is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sughanda Khanna, MD 615 Elsinore Pl Ste 200, Cincinnati, OH 45202-1457 Ph: (335) 104-3578	Sughanda Khanna, MD 501 West Market St, Ste 105, Georgetown, DE 19947 Ph: (302) 303-5491

News Archive

Nutritional supplement may reduce risk of fatal strokes in patients with rare genetic disorder

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered that a widely used nutritional supplement may significantly reduce the risk of fatal strokes caused by a rare genetic disorder.

Scleroderma Foundation names Tulane professor as 'Doctor of the Year'

Dr. Lesley Ann Saketkoo, an associate professor of clinical medicine at Tulane University School of Medicine, has been named Doctor of the Year by the Scleroderma Foundation. The award recognizes leadership and commitment to the community battling scleroderma, a disabling and life-limiting multi-organ autoimmune disease with progressive lung, heart, kidney, gastrointestinal tract and/or vascular involvement.

Overcoming the big ‘nanotech' challenges

Whether in the fields of medicine, sustainable energy supply or environmental protection, without making use of nanotechnology we will not be capable of overcoming the challenges which the future presents. In parallel with these efforts, though, it is essential that we examine the new technology very carefully for potential risks, such as those presented by free nanoparticles.

Study reveals novel indicator of protection against influenza virus infection

A study of influenza virus transmission in Nicaraguan households reveals new insights into the type of immune responses that may be protective against influenza virus infection, report investigators.

New guidelines allow definition of pre-Alzheimer's

The emphasis on the need to diagnose Alzeheimer's during its earliest stages is also evident in Congress, where legislation introduced this month would create new, specific Medicare cost codes for early-disease diagnosis to address these steps, including the discussions between the physician and caregivers.

Sughanda Khanna, MD - Medicare in Georgetown, DE